ImmunoGen Announces Proposed Public Offering of Common Stock; No Amount Given
ImmunoGen, Inc. (Nasdaq: IMGN) announced today that it intends to offer for sale its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.